Visit the AHRP blog:
http://ahrp.blogspot.com
Top News arrow Safety Issues arrow Psychotropic Drugs
Psychotropic Drugs
Addictive Qualities of Modafinil Not Discussed by FDA Advisory PDF Print E-mail
Tuesday, 28 March 2006

The focus of a recent FDA's Psychopharmacology Advisory Committee meeting, was the drug, modafinil (as Sparlon), for ADHD and the risk of
Steven-Johnson's, a rare but potentially fatal, skin condition. 

Read more...
 
"Some of the children were prescribed anti-psychotics, rather than discontinued from ADHD therapy." PDF Print E-mail
Tuesday, 28 March 2006
"That thing I'm worried about...where the MedGuide would help, where it might even warrant a black box, if this is common, where somebody hallucinates and then gets put on an anti-psychotic drug. That would really be something worth making sure it doesn't happen,"
Read more...
 
AHRP Recommends FDA Actions to Protect Children Rx ADHD drugs PDF Print E-mail
Tuesday, 21 March 2006
AHRP Urges Actions to Minimize Risks for Children prescribed psychotropic drugs: Action is needed to protect children from widespread prescribing of psychoactive drugs for ill-defined behavioral symptoms.
Read more...
 
2.5 Million US Children Prescribed Antipsychotics_ FDA ADHD--ADR Review PDF Print E-mail
Friday, 17 March 2006
The Associated Press reports that a just released study that found that a staggering, two and half million children in the U.S. are being prescribed antipsychotics annually--that's 40 out of every 1,000 children.
Read more...
 
Fix the Diagnosis, Not the Children PDF Print E-mail
Tuesday, 07 March 2006
From both sides of the Atlantic, even psychiatrists are acknowledging--the ADHD diagnosis makes no sense.
Read more...
 
<< Start < Prev 1 2 3 4 5 Next > End >>

Results 28 - 36 of 42
(C) 2008 Alliance for Human Research Protection
CMS installation and website development by Anne Krauss

General Terms & Disclaimer:

This site is not a monologue of truth. It is a catalyst for public debate about medical research conduct. The reader is urged to confront officials to clarify issues mentioned herein. This site is designed strictly to provide information for critical, literary, academic an public usage. A qualified and trustworthy medical professional must be consulted regarding medical issues, treatments, diagnoses, etc.

Please read the General Terms and Conditions of this agreement entirely and carefully before accessing this web site. By accessing the site, you agree to be bound by the terms and conditions listed herein. [continue]